Sonio, a MedTech startup that specializes in prenatal diagnosis and screening, has raised €5 million in a funding round led by Elaia, Bpifrance, and Oneragtime. The funding round was completed after 2CFinance performed financial due diligence on the company. Sonio uses AI to aid physicians and ultrasound technicians in the performance of fetal ultrasounds, and their software includes "Sonio diagnostic" to assist physicians in making the correct diagnosis, and "Sonio screening" to assist ultrasound technicians during prenatal screening exams.
Cécile Brosset and Dagmar Nuber founded Sonio in 2020 to develop SaaS solutions that assist practitioners in conducting pregnancy monitoring ultrasounds. Sonio's latest funding round will help the company add integrated image recognition to its platform and expand its operations to the United States, as well as accelerate sales processes throughout Europe.
Elaia, an early-stage venture capital firm, has been investing in startups for over 17 years. They focus on companies in the digital economy, such as SaaS, marketplaces, and AI. Bpifrance, a French investment bank, provides financing and investment solutions to companies located in France. They offer several financing solutions, such as equity financing, loans, and guarantees. Oneragtime, a venture capital firm, invests in early-stage technology startups in Europe and Israel.
Sonio's recent funding round will aid the company in expanding its operations, adding new features to its platform, and increasing its sales processes. The funding round was led by Elaia, Bpifrance, and Oneragtime, all of whom are prominent investors in the European startup ecosystem.